PR Newswire: news distribution, targeting and monitoring
2014

Coherent, Inc. Reports Second Fiscal Quarter Results

Share with Twitter Share with LinkedIn

SANTA CLARA, Calif., April 24, 2013 /PRNewswire/ -- Coherent, Inc. (NASDAQ: COHR), a world leader in providing photonics based solutions to the commercial and scientific research markets, today announced financial results for its second fiscal quarter ended March 30, 2013.

FINANCIAL HIGHLIGHTS



Three Months Ended


Six Months Ended

GAAP Results

(in millions except per share data)

March 30,


Dec. 29,


March 31,


March 30,


March 31,

2013


2012


2012


2013


2012

Bookings

$201.8


$176.0


$183.1


$377.8


$385.0

Net sales

$200.1


$183.2


$193.3


$383.3


$384.1

Net income

$15.0


$14.2


$16.2


$29.2


$33.2

Diluted EPS

$0.61


$0.58


$0.67


$1.20


$1.38











Non-GAAP Results










(in millions except per share data)










Net income

$20.7


$18.6


$18.6


$39.3


$39.4

Diluted EPS

$0.84


$0.77


$0.77


$1.61


$1.64

 

SECOND FISCAL QUARTER DETAILS

For the second fiscal quarter ended March 30, 2013, Coherent announced net sales of $200.1 million and net income, on a U.S. generally accepted accounting principles (GAAP) basis, of $15.0 million, or $0.61 per diluted share.  These results compare to net sales of $193.3 million and net income of $16.2 million, or $0.67 per diluted share, for the second quarter of fiscal 2012. Non-GAAP net income for the second quarter of fiscal 2013 was $20.7 million, or $0.84 per diluted share.  Non-GAAP net income for the second quarter of fiscal 2012 was $18.6 million, or $0.77 per diluted share. We have revised our presentation of non-GAAP net income and non-GAAP diluted EPS for all periods presented to exclude the effect of intangibles amortization and inventory step up costs. For a complete overview of the differences between GAAP and non-GAAP results, please see the reconciliation table included at the end of our release.

Net sales for the first quarter of fiscal 2013 were $183.2 million and net income, on a GAAP basis, was $14.2 million, or $0.58 per diluted share. Non-GAAP net income for the first quarter of fiscal 2013 was $18.6 million, or $0.77 per diluted share.

Bookings received during the second fiscal quarter ended March 30, 2013 of $201.8 million increased 10.2% from $183.1 million in the same prior year period and increased by 14.7% compared to bookings of $176.0 million in the immediately preceding quarter.  The book-to-bill ratio was 1.01, resulting in backlog of $333.0 million at March 30, 2013, compared to a backlog of $348.1 million at December 29, 2012 and a backlog of $349.2 million at March 31, 2012.

"Demand improved across many of our commercial end markets.  We posted record bookings for materials processing including our first volume order for the Highlight™ 1000FL fiber laser for flatbed cutting, strong orders for the Highlight™ D-Series direct diode system for additive manufacturing and several orders for Diamond™ E-1000 lasers to be used in converting.  The advanced packaging (API) market continued to build momentum with orders rising sequentially and year-over-year due to rising demand for any layer HDI PCBs for mobile devices and high-end IC substrates.  Orders also picked up in the semicap market as utilization rates rose and end users increased their service needs and expanded capacity for advanced nodes. Bookings for medical OEM applications were at an all-time high and benefitted from our recent acquisition of Lumera Laser.  The only market to exhibit softness was the research market where stronger demand in Asia could not overcome the effects of sequestration in the U.S. and belt tightening in Europe," said John Ambroseo, Coherent's President and Chief Executive Officer.

Coherent ended the quarter with cash, cash equivalents and short term investments of $204.0 million, an increase of $24.2 million from cash, cash equivalents and short term investments of $179.8 million at December 29, 2012.

CONFERENCE CALL REMINDER

The Company will host a conference call today to discuss its financial results at 1:30 P.M. Pacific (4:30 P.M. Eastern). A listen-only broadcast of the conference call can be accessed on the Company's website at either http://www.coherent.com/Investors/ or http://www.earnings.com. For those who are not able to listen to the live broadcast, the call will be archived for approximately three months on both web sites.  A transcript of management's prepared remarks can be found at http://www.coherent.com/Investors/.

Summarized statement of operations information is as follows (unaudited, in thousands except per share data):



Three Months Ended


Six Months Ended


March 30,


Dec. 29,


March 31,


March 30,


March 31,


2013


2012


2012


2013


2012











Net sales

$200,058


$183,202


$193,284


$383,260


$384,051

Cost of sales (A) (B) (C) (D)

123,727


105,567


115,636


229,294


226,044

Gross profit

76,331


77,635


77,648


153,966


158,007

Operating expenses:










Research & development (A) (B)

20,146


19,301


20,323


39,447


39,102

Selling, general & administrative (A) (B)

37,346


36,982


35,377


74,328


70,008

Intangibles amortization (C)

1,942


854


1,611


2,796


3,247

Total operating expenses

59,434


57,137


57,311


116,571


112,357

Income from operations

16,897


20,498


20,337


37,395


45,650

Other income (expense), net (B)

1,295


(1,437)


1,912


(142)


2,430

Income before income taxes

18,192


19,061


22,249


37,253


48,080

Provision for income taxes (E)

3,190


4,908


6,094


8,098


14,874

Net income

$15,002


$14,153


$16,155


$29,155


$33,206











Net income per share:










Basic

$0.62


$0.60


$0.69


$1.22


$1.41

Diluted

$0.61


$0.58


$0.67


$1.20


$1.38











Shares used in computation:










Basic

24,085


23,770


23,521


23,928


23,491

Diluted

24,475


24,222


23,996


24,348


23,979

 

(A)   

Stock-related compensation expense included in operating results is summarized below (all footnote amounts are unaudited, in thousands, except per share data):

 

Stock-related compensation expense

Three Months Ended


Six Months Ended


Mar. 30,


Dec. 29,


Mar. 31,


Mar. 30,


Mar. 31,


2013


2012


2012


2013


2012

Cost of sales

$594


$435


$441


$1,029


$810

Research & development

467


476


431


943


824

Selling, general & administrative

3,581


4,083


3,288


7,664


6,548

Impact on income from operations

$4,642


$4,994


$4,160


$9,636


$8,182

For the quarters ended March 30, 2013, December 29, 2012, and March 31, 2012, the impact on net income, net of tax was $3,497 ($0.14 per diluted share), $3,511 ($0.14 per diluted share) and $2,895 ($0.12 per diluted share), respectively. For the six months ended March 30, 2013 and March 31, 2012, the impact on net income, net of tax was $7,008 ($0.29 per diluted share) and $5,589 ($0.23 per diluted share), respectively.

(B)   

Changes in deferred compensation plan liabilities are included in cost of sales and operating expenses while gains and losses on deferred compensation plan assets are included in other income (expense) net.  Deferred compensation expense (benefit) included in operating results is summarized below:

 

Deferred compensation expense (benefit)

Three Months Ended


Six Months Ended


Mar. 30,


Dec. 29,


Mar. 31,


Mar. 30,


Mar. 31,


2013


2012


2012


2013


2012

Cost of sales

$37


$14


$46


$51


$50

Research & development

149


62


213


211


232

Selling, general & administrative

1,066


426


1,439


1,492


1,555

Impact on income from operations

$1,252


$502


$1,698


$1,754


$1,837

 

For the quarters ended March 30, 2013, December 29, 2012 and March 31, 2012, the impact on other income (expense) net from gains or losses on deferred compensation plan assets was income of $983, income of $294 and income of $1,541, respectively. For the six months ended March 30, 2013 and March 31, 2012, the impact on other income (expense) net was income of $1,277 and income of $1,487, respectively.

(C)   

For the three and six months ended March 30, 2013, the impact of amortization of intangibles expense was $3,408 ($2,775 net of tax ($0.11 per diluted share)) and $4,589 ($3,642 net of tax ($0.15 per diluted share)), respectively. For the three and six months ended March 31, 2012, the impact of amortization of intangibles expense was $1,611 ($1,162 net of tax ($0.05 per diluted share)) and $3,247 ($2,244 net of tax ($0.09 per diluted share)), respectively.


(D)   

For the three and six months ended March 30, 2013, the impact on net income of our inventory step up costs related to our recent acquisitions, was $1,130 ($791 net of tax ($0.03 per diluted share)) and $1,222 ($855 net of  tax ($0.04 per diluted share)), respectively.


(E)   

The three and six months ended March 30, 2013 included $1,398 ($0.06 per diluted share) benefit from the renewal of the R&D tax credit for fiscal 2012. The three and six months ended March 31, 2012 included $1,647 ($0.07 per diluted share) release of tax reserves and related interest as a result of the closure of open tax years.

 

Summarized balance sheet information is as follows (unaudited, in thousands):



March 30,
2013


September 29,
2012

ASSETS




Current assets:




Cash, cash equivalents and short-term investments

$203,990


$224,929

Accounts receivable, net 

134,479


144,345

Inventories  

166,865


160,113

Prepaid expenses and other assets 

80,765


85,098

Total current assets    

586,099


614,485

Property and equipment, net 

114,368


115,096

Other assets  

222,896


151,191

Total assets   

$923,363


$880,772





LIABILITIES AND STOCKHOLDERS' EQUITY




Current liabilities:




Current portion of long-term obligations

$ 11


$ 17

Accounts payable 

39,443


29,088

Other current liabilities

131,970


124,683

Total current liabilities

171,424


153,788

Other long-term liabilities 

64,663


55,328

Total stockholders' equity

687,276


671,656

Total liabilities and stockholders' equity

$923,363


$880,772

 

Reconciliation of GAAP to Non-GAAP net income (unaudited, in thousands, net of tax):



Three Months Ended


Six Months Ended


Mar. 30,
2013


Dec. 29,

2012


Mar. 31,
2012


Mar. 30,
2013


Mar. 31,
2012

GAAP net income

$15,002


$14,153


$16,155


$29,155


$33,206

Stock-related compensation expense

3,497


3,511


2,895


7,008


5,589

Intangibles amortization

2,775


867


1,162


3,642


2,244

Inventory step-up

791


64


--


855


--

Non-recurring tax expense (release) items

(1,398)


--


(1,647)


(1,398)


(1,647)

Non-GAAP net income

$20,667


$18,595


$18,565


$39,262


$39,392


Non-GAAP net income per diluted share

$ 0.84


$ 0.77


$ 0.77


$ 1.61


$ 1.64



Founded in 1966, Coherent, Inc. is a world leader in providing photonics based solutions to the commercial and scientific research markets and part of the Standard & Poor's SmallCap 600 Index and the Russell 2000. Please direct any questions to Leen Simonet, Chief Financial Officer at 408-764-4110. For more information about Coherent, visit the Company's Web site at http://www.coherent.com/ for product and financial updates.

SOURCE Coherent, Inc.



RELATED LINKS
http://www.coherent.com

Featured Video

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Share with Twitter Share with LinkedIn
 

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

 
 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

 
 

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.

 
Area to test

Online Member Center

Not a Member?
Click Here to Join
Login
Search News Releases
Advanced Search
Search
  1. PR Newswire Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
  5. Send a News Release